Research Toward a Cure for Perinatal HIV

Clin Perinatol. 2024 Dec;51(4):895-910. doi: 10.1016/j.clp.2024.08.006. Epub 2024 Sep 13.

Abstract

In virtually all people living with HIV-1 (PLWH), including children, HIV-1 integrates and becomes latent in CD4+ T cells, forming a latent HIV-1 reservoir that current antiretroviral drugs and immune surveillance mechanisms cannot target. This latent infection in CD4+ T cells renders HIV-1 infection lifelong and incurable. Consequently, there is intense research focused on identifying therapeutic strategies to reduce and control the latent reservoir, aiming to avert a lifetime of antiretroviral therapy for PLWH. This review discusses the global efforts for children and adolescents living with HIV-1.

Keywords: ART-Free HIV-1 remission; HIV-1 cure; Perinatal HIV-1.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Anti-HIV Agents / therapeutic use
  • CD4-Positive T-Lymphocytes / immunology
  • Child
  • Female
  • HIV Infections* / drug therapy
  • HIV-1*
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical* / prevention & control
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy
  • Virus Latency*

Substances

  • Anti-HIV Agents